Clinical Trials Logo

Clinical Trial Summary

Cognitive impairment is the core symptom of unipolar and bipolar depression, which seriously affects the prognosis of the disease and the rehabilitation of social function. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. In this study,the THINC-it tool was used to study the characteristics of cognitive impairment in unipolar and bipolar depression by longitudinal follow-up, which provides a theoretical basis for the differential diagnosis of unipolar and bipolar depression. Early identification and intervention of risk factors can improve the prognosis of the disease.


Clinical Trial Description

there is some cognitive impairment in patients with unipolar and bipolar depression. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. The THINC-it is a simple, fast and free cognitive assessment tool for cognitive impairment screening of unipolar and bipolar depression. This study includes three steps. 1. baseline: demographic data, theTHINC-it tool , clinical scales(HAMD-17,HAMA、YMRS、PSQI) evaluation and Laboratory examination(blood glucose, blood lipids, BMI) 2. follow-up (4 week): Clinical scales and THINC-it tool were evaluated in unipolar and bipolar depression. 3. follow-up (12 weeks): all patients with bipolar depression were evaluated by clinical scales, THINC-it test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05053204
Study type Observational
Source Shanghai Mental Health Center
Contact Jun Chen, M.D., Ph.D
Phone 021-34773367
Email doctorcj2010@gmail.com
Status Recruiting
Phase
Start date May 15, 2021
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT04470219 - Digital Support for People With Cognitive Impairment N/A
Completed NCT01071044 - Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome Phase 4
Completed NCT02962687 - Video-Enhanced Care Management for Medically Complex Veterans N/A
Completed NCT01324024 - Attention & Memory Impairments in Menopausal Women Phase 4
Recruiting NCT02778581 - Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment N/A
Suspended NCT00197483 - Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia Phase 2
Completed NCT05585424 - Effectiveness of a Program Based on Observation-action Training (AOT) in Patients With Cognitive Impairment. N/A
Completed NCT05822596 - Tablet-based Interactive Games in Elderly With Cognitive Impairment and Persons With Intellectual Disability N/A
Completed NCT02830854 - Molecular Hydrogen for Cognitive Function and Performance in Elderly Phase 3
Withdrawn NCT01986777 - LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy N/A
Recruiting NCT01466205 - Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder Phase 2
Recruiting NCT05896189 - Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors N/A
Not yet recruiting NCT06212726 - RTL Concussion Communication N/A
Completed NCT02868684 - Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
Recruiting NCT04490330 - Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients
Completed NCT02677987 - The "Light for the Brain" Study N/A
Completed NCT02746484 - ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program N/A